Redwood City, CA
United States
Bristol Myers Squibb - Immuno-Oncology Discovery
Dysfunctional CD8+ T cells, CD226 (DNAM-1), CD155 (PVR), Cancer immunotherapy, Melanoma, HNSCC, adoptive cell transfer therapy